BioAge Labs, Inc. BIOA
5.95 USD +0.15 (+2.50%)
Nov 3, 2026, 3:49 PM EST
5.58 Day range 6.01
4.81 52-week range 25.96
- YTD
- -55.06%
- 1 year
- -19.88%
Financial health
Altman Z-Score
4.86 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -5.9×
FY 2022 5y median -7.8× FY 2025
P/S 52.9×
FY 2022 5y median 0.0× FY 2025
P/B 1.7×
FY 2022 5y median -1.5× FY 2025
P/FCF -5.8×
FY 2022 5y median -11.2× FY 2025
EV/EBITDA -3.7×
FY 2022 5y median -7.7× FY 2025
EV/Sales 32.5×
FY 2022 5y median 0.0× FY 2025
FCF Yield -17.3%
FY 2022 5y median -11.7% FY 2025
Profitability
Gross Margin 100.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin -1031.5%
FY 2022 5y median 0.0% FY 2025
Net Margin -896.1%
FY 2022 5y median 0.0% FY 2025
ROE -29.6%
FY 2022 5y median 6.6% FY 2025
ROIC -33.4%
FY 2022 5y median -104.4% FY 2025
ROA -27.3%
FY 2022 5y median -83.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -18.7%
FY 2022 FY 2025
EPS (diluted) -13.1%
FY 2022 FY 2025
Free Cash Flow -58.7%
FY 2022 FY 2025
Financial Health
Current Ratio 14.2×
FY 2022 5y median 8.8× FY 2025
Quick Ratio 14.2×
FY 2022 5y median 8.8× FY 2025
Debt / Equity 0.0×
FY 2022 5y median -0.0× FY 2025
Net Debt / EBITDA 2.3×
FY 2022 5y median 1.5× FY 2025
Interest Coverage -133×
FY 2022 5y median -83.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31